DNA Splicing

Enhancers:
Enhancers are regulatory regions in eukaryotic genes that can increase or enhance transcription.
They are not necessarily located close to the genes they regulate and can be found upstream,
downstream, within the coding region, or even thousands of nucleotides away from the gene.
Enhancer regions contain binding sequences for specific transcription factors.
When a transcription factor binds to an enhancer sequence, it undergoes a conformational

change, enabling it to interact with proteins at the promoter site.
Since enhancer regions may be far from the promoter, the DNA must bend to bring the enhancer
and promoter regions into contact.
DNA bending proteins facilitate this bending and bring the enhancer and promoter regions
together, allowing for interaction between the activator proteins bound to the enhancers and the
general transcription factors bound to the promoter, along with RNA polymerase.
Transcriptional Repressors:
Transcriptional repressors are proteins that can bind to promoter or enhancer regions and
inhibit transcription.
Similar to activators, repressors respond to external stimuli to modulate gene expression by

preventing the binding of activating transcription factors.
They function by blocking the initiation of transcription or inhibiting the interaction between
activators and the transcriptional machinery.
In summary, enhancers and transcriptional repressors are key regulatory elements in eukaryotic gene
expression, playing roles in enhancing or inhibiting transcription in response to cellular signals and
environmental cues. They contribute to the precise control and regulation of gene expression,
allowing cells to adapt to changing conditions and maintain homeostasis. RNA Splicing:
In eukaryotic cells, the primary transcript (pre-mRNA) often contains regions called introns,
which are non-coding sequences.
The coding regions of RNA, called exons, are interspersed with these introns.
Before leaving the nucleus for translation, the pre-mRNA undergoes processing, during which
the introns are removed and the exons are joined together in a process known as splicing.
Splicing is mediated by spliceosomes, which are ribonucleoprotein complexes that recognize the
splice sites at the ends of introns, cut the pre-mRNA at these sites, and ligate the adjacent exons
together.
Alternative RNA Splicing:
Alternative RNA splicing is a mechanism that allows different protein isoforms to be generated
from a single gene by combining different combinations of exons.
This process can be controlled and serves as a mechanism of gene regulation, allowing cells to
produce different protein products in response to various signals or developmental stages.
Alternative splicing is estimated to occur in approximately 70% of human genes.
Despite the variations in splicing, the original order of exons along the RNA transcript (from 5' to
3') is generally conserved.
Evolutionary Implications:
Alternative splicing could have evolved through mutations that affect the recognition sequences
at the ends of introns, leading to the inclusion or exclusion of different exons.
While some splicing errors may result in non-functional proteins, alternative splicing can also
generate protein variants with new functions, potentially contributing to adaptation and
evolutionary diversification.
Abnormal splicing, rather than mutations in coding sequences, is often the cause of genetic
diseases.
The question provided at the end relates to the insertion of a transposable element into an intron of
the OCA2 gene in corn snakes, resulting in amelanism. This insertion disrupts the normal splicing
process, potentially leading to the production of non-functional or altered proteins, which can
manifest as phenotypic traits such as altered pigmentation in snakes.. Thus, miRNAs play a crucial
role in post-transcriptional gene regulation by controlling the stability and translation of mRNA
molecules.
This passage highlights several key points regarding the control of RNA stability:
Protective Caps: The mRNA molecule is capped at its 5' and 3' ends to protect it from degradation
by exonucleases.
RNA Stability: The lifespan of an RNA molecule and its decay rate influence the amount of protein
synthesized. RNA stability refers to the rate of decay of an RNA molecule, which can be controlled to
regulate protein expression levels.
RNA-Binding Proteins (RBPs): RBPs bind to specific regions in the mRNA called untranslated regions
(UTRs), influencing RNA stability. These regions include the 5' UTR and the 3' UTR.
microRNAs (miRNAs): miRNAs are short RNA molecules that can bind to mRNA and regulate gene
expression. They are processed from longer pre-miRNAs by Dicer and then associate with the RISC
complex. miRNAs base-pair with complementary sequences on mRNA molecules, leading to
translational repression or mRNA degradation.
Overall, RNA stability is a critical aspect of post-transcriptional gene regulation, and it can be
modulated by various factors, including RNA-binding proteins and microRNAs, to finely tune protein
expression levels in the cell. Increased phosphorylation levels of eIF-2, as observed in patients with
neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s, would have a
significant impact on protein synthesis. Phosphorylation of eIF-2 prevents its binding to GTP, leading
to impaired formation of the translation initiation complex and subsequently inhibiting translation.
This means that the initiation of protein synthesis would be disrupted, resulting in reduced
production of proteins necessary for normal cellular functions.
In neurodegenerative diseases, where protein aggregates and misfolded proteins are common
pathological features, impaired protein synthesis due to increased phosphorylation of eIF-2 could
exacerbate cellular dysfunction and contribute to disease progression. Since protein synthesis is
essential for maintaining neuronal function and survival, the impairment of translation initiation can
lead to neuronal degeneration and cognitive decline characteristic of these diseases.
Disease Implications: Dysregulation of these mechanisms can contribute to the pathogenesis of

diseases, including neurodegenerative disorders, highlighting the importance of understanding
protein synthesis regulation in health and disease.

DNA Splicing

Uploaded by

Copyright:

Available Formats

DNA Splicing

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

DNA Splicing

Uploaded by

Copyright:

Available Formats

Enhancers:

Enhancer regions contain binding sequences for specific transcription factors.

When a transcription factor binds to an enhancer sequence, it undergoes a conformational

Similar to activators, repressors respond to external stimuli to modulate gene expression by

Alternative RNA Splicing:

Alternative splicing is estimated to occur in approximately 70% of human genes.

Disease Implications: Dysregulation of these mechanisms can contribute to the pathogenesis of

You might also like